已收录 272923 条政策
 政策提纲
  • 暂无提纲
Development and validation of a GC-FID assay for determination of fluvastatin in pharmaceutical preparations
[摘要] A gas chromatographic method has been developed for the assay of fluvastatin sodium (FLU). FLU was silylated with N,O-bis(trimethylsilyl)trifluoroacetamide-1% trimethylchlorosilane at 90 ºC for 30 min and analysed in a DB-1 column by capillary gas chromatograph with a flame ionization detector. The method was validated. The assay was linear over the concentration range at 10.0 to 50.0 µg mL-1. The limit of detection and the limit of quantitation were 1.0 and 3.0 µg mL-1, respectively. The recoveries of FLU derivatives were in the range of 99.25-99.80%. In inter-day and intra-day analysis, the values of relative standard deviation (%) and the relative mean error (%) were found between 0.20-0.80% and -0.20-0.75%, respectively. The developed method was succesfully applied to analyze the FLU content in tablet formulation. The results were statistically compared with those obtained by the official method, and no significant difference was found between the two methods. Therefore, it can be recommended for the quality control assay of FLU in pharmaceutical industry.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 化学(综合)
[关键词] fluvastatin;validation;pharmaceutical preparations. [时效性] 
   浏览次数:4      统一登录查看全文      激活码登录查看全文